Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OsteoScreen Inc.

www.osteoscreen.com

Latest From OsteoScreen Inc.

Neosil Inc.

Neosil Inc. intends to develop NCEs for unmet needs in dermatology. Something of a rarity these days, Neosil intends to become a real pharmaceutical company, taking selected products through regulatory approval to the US market by itself.
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • OsteoScreen Inc.
  • Senior Management
  • Gregory R Mundy, MD, Pres.
  • Contact Info
  • OsteoScreen Inc.
    Phone: (210) 614-0770
    2040 Babcock Rd.
    Ste. 201
    San Antonio, TX 78229
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register